LifewardLFWD -1.74%56 PB Ratio is 3.13 as of Jun. 29, 2026, which is 177% above its 10-year median of 1.13. GuruFocus rates LFWD with a GF Score™ of 56/100 and a GF Value™ of $13.73 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 786 Medical Devices & Instruments companies, Lifeward ranks worse than 67.05% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-06-29), Lifeward's share price is $7.075. Lifeward's Book Value per Share for the quarter that ended in Mar. 2026 was $2.26. Hence, Lifeward's PB Ratio of today is 3.13.
Warning Sign:
Lifeward Ltd stock PB Ratio (=3.18) is close to 5-year high of 3.47.
The historical rank and industry rank for Lifeward's PB Ratio or its related term are showing as below:
LFWD'
s PB Ratio Range Over the Past 10 Years
Min: 0.31 Med: 1.13 Max: 23.9
Current: 3.13
During the past 13 years, Lifeward's highest PB Ratio was 23.90. The lowest was 0.31. And the median was 1.13.
LFWD's PB Ratio is ranked worse than 67.05% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 2.015
vs LFWD: 3.13
During the past 12 months, Lifeward's average Book Value Per Share Growth Rate was -89.10% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -61.30% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -40.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -36.70% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Lifeward was 26.80% per year. The lowest was -74.30% per year. And the median was -37.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Lifeward PB Ratio Related Terms
Lifeward PB Ratio Historical Data
* Premium members only.
The historical data trend for Lifeward's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Lifeward's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lifeward PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lifeward's PB Ratio distribution charts can be found below:
* The bar in red indicates where Lifeward's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Lifeward's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Lifeward (LFWD) has a PB Ratio of 3.13 as of Jun. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Lifeward and its competitors. This is 177% above median its historical median of 1.13. Over the past decade, Lifeward's PB Ratio has ranged from 0.31 to 23.90. According to the industry distribution chart, Lifeward ranks #527 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 67%.
Is Lifeward's PB Ratio too high?
Lifeward's current PB Ratio of 3.13 is 177% above median its 10-year median of 1.13. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 23.90. The Medical Devices & Instruments industry median PB Ratio is 2.02. Lifeward's value of 3.13 is 55.3% above this industry median. Based on the distribution chart, Lifeward ranks #527 out of 786 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Lifeward has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Lifeward's PB Ratio compare to ICCM and IRIX?
According to the Medical Devices & Instruments industry distribution chart, Lifeward ranks #527 out of 786 companies for PB Ratio. This places Lifeward in the lower half of its industry. The industry median PB Ratio is 2.02. Lifeward's value of 3.13 is 55.3% above this benchmark. Historically, Lifeward's own PB Ratio has ranged from 0.31 to 23.90 over the past decade. While the company's 10-year median is 1.13 vs. the industry median of 2.02, Lifeward has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lifeward's current PB Ratio of 3.13 is 55.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Lifeward and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lifeward's current PB Ratio is 3.13, which is 177% above median its own 10-year median of 1.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lifeward stock overvalued right now?
Based on GuruFocus' analysis, Lifeward (LFWD) is currently considered Possible Value Trap. The stock's GF Value™ is $13.73, compared to a current price of $7.08 — trading 48.5% below its estimated fair value. The current PB Ratio is 3.13, which is 177% above median its 10-year median of 1.13 and 55.3% above the Medical Devices & Instruments industry median of 2.02. Lifeward's overall GF Score™ is 56/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Lifeward (LFWD), the current PB Ratio is 3.13 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lifeward (LFWD) Overvalued in 2026?
Based on GuruFocus' analysis, Lifeward stock appears to be undervalued.
The current stock price of $7.08 is trading 48.5% below its estimated GF Value™ of $13.73.
GuruFocus considers Lifeward to be Possible Value Trap.
Key valuation signals for LFWD:
PB Ratio: 3.13 (177% above median its 10-year median of 1.13)
GF Value™: $13.73 vs. price of $7.08 (48.5% below fair value)
Industry Position: 55.3% above the Medical Devices & Instruments median (#527 of 786)
No single metric tells the full story. See the LFWD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
56GF Score
Get the complete analysis for LFWD
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFWD has been successfully added to your 
